Evidence map›Paper›PMID 33202851›Full record

ArticleAntioxidants (Basel, Switzerland)2020

Antioxidant Lifestyle, Co-Morbidities and Quality of Life Empowerment Concerning Liver Fibrosis.

Diego Martinez-Urbistondo, Rafael Suarez Del Villar, Josepmaria Argemí, Lidia Daimiel, Omar Ramos-López, Rodrigo San-Cristobal, Paula Villares, Jose Alfredo Martinez

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Antioxidant Foods and Cardiometabolic Health.Antioxidants (Basel, Switzerland) · 2022
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Diego Martinez-UrbistondoInternal Medicine Department, Hospital HM Sanchinarro, HM Hospitales, 28050 Madrid, Spain.
Rafael Suarez Del VillarInternal Medicine Department, Hospital HM Sanchinarro, HM Hospitales, 28050 Madrid, Spain.
Josepmaria ArgemíLiver Unit, Clínica Universidad de Navarra, Centro de Investigación Médica Aplicada, 31008 Pamplona, Spain.
Lidia DaimielPrecision Nutrition Program, Instituto Madrileño de Estudios Avanzados, Universidad Autónoma de Madrid, 28049 Madrid, Spain.ORCID 0000-0001-9898-6629
Omar Ramos-LópezMedicine and Psychology School, Autonomous University of Baja California, Tijuana 22390, Mexico.ORCID 0000-0002-2505-1555
Rodrigo San-CristobalPrecision Nutrition Program, Instituto Madrileño de Estudios Avanzados, Universidad Autónoma de Madrid, 28049 Madrid, Spain.ORCID 0000-0001-8054-6553
Paula VillaresInternal Medicine Department, Hospital HM Sanchinarro, HM Hospitales, 28050 Madrid, Spain.
Jose Alfredo MartinezPrecision Nutrition Program, Instituto Madrileño de Estudios Avanzados, Universidad Autónoma de Madrid, 28049 Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The assessment of liver fibrosis has gained importance since the progression of non-alcoholic fatty liver disease (NAFLD). Indeed, the description of the association between undetected liver fibrosis and lifestyle in terms of antioxidant habits, comorbidity and quality of life (QoL) domains may help in the characterization of subjects with NAFLD. A cross-sectional evaluation of (

Indexed as

antioxidant lifestylecomorbidityhealth empowermentliver fibrosisquality of liferedox statuswellbeing

Identifiers

PMID33202851
PMCPMC7696605

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.